MED

Value 202020212022202320242025 TTM Total revenue 934.84 M1.53 B1.6 B1.07 B602.46 M385.79 M 385.79 M Gross profit 697.82 M1.13 B1.14 B775.85 M444.62 M275.19 M 275.19 M Operating expenses 567.12 M915.84 M957.99 M652.88 M449.57 M292.33 M 288.03 M Selling/general/admin expenses 563.66 M911.36 M955.61 M649.45 M441.75 M289.4 M 289.4 M Research & development 2.8 M4.4 M4.5 M4.6 M4.6 M4.3 M — Operating income 134.16 M216.24 M184.81 M126.4 M2.88 M14.21 M 14.21 M Non-Operating Income, Total 106 K112 K747 K2.4 M909 K8.57 M 8.57 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses -34 K-7 000701 K2.3 M4.8 M5.52 M 9.97 M Unusual income/expense 140 K119 K46 K95 K-3.9 M3.06 M — Pretax income 134.26 M216.13 M184.06 M128.8 M3.79 M5.64 M 5.64 M Equity in earnings —————— — Taxes 31.41 M52.1 M40.49 M29.38 M1.7 M13.03 M 13.03 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 102.86 M164.03 M143.57 M99.42 M2.09 M18.67 M 18.67 M Discontinued operations —————— — Net income 102.86 M164.03 M143.57 M99.42 M2.09 M18.67 M 18.67 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 102.86 M164.03 M143.57 M99.42 M2.09 M18.67 M 18.67 M Basic earnings per share (Basic EPS) 8.7414.0112.829.130.19-1.7 -1.7 Diluted earnings per share (Diluted EPS) 8.6813.8912.739.10.19-1.7 -1.7 Average basic shares outstanding 11.77 M11.71 M11.2 M10.88 M10.93 M10.98 M 43.91 M Diluted shares outstanding 11.85 M11.81 M11.28 M10.92 M10.96 M10.98 M 43.98 M EBITDA 137.97 M218.57 M193.4 M136.08 M7.76 M-2.9 M 1.4 M EBIT 130.69 M211.75 M182.42 M122.97 M-4.95 M-17.14 M -12.84 M Cost of revenue 237.03 M398.49 M458.16 M296.2 M157.84 M110.6 M 110.6 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 7.27 M6.81 M10.98 M13.11 M12.71 M14.24 M 14.24 M